SCHEMBL15036504

SCHEMBL15036504

CCCC1=C(O)/C(=N\c2ccc(O)c(Cl)c2)C=C(Nc2ccc(O)c(Cl)c2)C1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 1/20 0.35
▸ TDO2 P48775 1/20 0.35
▸ PTGS1 P23219 1/20 0.34
▸ PTGS2 P35354 1/20 0.34
▸ GSK3B P49841 4/20 0.33
▸ STK10 O94804 2/20 0.32
▸ SLK Q9H2G2 2/20 0.32
▸ ADORA2A P29274 1/20 0.31
▸ ADORA1 P30542 1/20 0.31
▸ GSK3A P49840 1/20 0.31
▸ BRDT Q58F21 1/20 0.31
▸ MAPT P10636 3/20 0.31
▸ HSD17B3 P37058 1/20 0.31
▸ HSD17B2 P37059 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ APAF1 O14727 1/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15039552 0.90 PTGS1 (0.36) IDO1TDO2PTGS1PTGS2GSK3B
SCHEMBL16426662 0.81 RAB9A (0.42) MAPTALDH1A1LMNAMEN1APAF1
SCHEMBL16426672 0.81 IDO1 (0.42) IDO1TDO2PTGS1PTGS2GSK3B
SCHEMBL16426665 0.79 RAB9A (0.34) MAPTMEN1APAF1NPC1POLB
SCHEMBL15020067 0.76 DNM1 (0.42) IDO1TDO2PTGS1PTGS2GSK3B
SCHEMBL15039580 0.76 DNM1 (0.42) IDO1TDO2PTGS1PTGS2GSK3B
SCHEMBL15020065 0.76 DNM1 (0.42) IDO1TDO2PTGS1PTGS2GSK3B
SCHEMBL15020486 0.75 DNM1 (0.38) IDO1TDO2PTGS1PTGS2GSK3B
SCHEMBL15020488 0.75 DNM1 (0.38) IDO1TDO2PTGS1PTGS2GSK3B
SCHEMBL16426675 0.75 DNM1 (0.38) IDO1TDO2PTGS1PTGS2GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9439844-B2 Tri-aromatic azomethine direct dyes comprising at least one unit derived from resorcinol, dyeing composition, method and use L'OREAL (FR) 2016-09-13 — — US disclosed
US-20150027483-A1 TRI-AROMATIC AZOMETHINE DIRECT DYES COMPRISING AT LEAST ONE UNIT DERIVED FROM RESORCINOL, DYEING COMPOSITION, METHOD AND USE L'OREAL (FR) 2015-01-29 — — US disclosed
WO-2013087772-A1 TRI-AROMATIC AZOMETHINE DIRECT DYES COMPRISING AT LEAST ONE UNIT DERIVED FROM RESORCINOL, DYEING COMPOSITION, METHOD AND USE L'OREAL (FR) 2013-06-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150027483-A1 TRI-AROMATIC AZOMETHINE DIRECT DYES COMPRISING AT LEAST ONE UNIT DERIVED FROM RESORCINOL, DYEING COMPOSITION, METHOD AND USE KRT18, IK, MKI67 IDO1 264/4885TDO2 182/4885PTGS1 3385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback